ARCHIVES

FDA Approves Rituxan For CLL

This article is from The Cancer Letter archive.

Vol. 36 No. 06 | February 19, 2010

Download PDF Visit The Full Archive

Related Articles

Funding opportunities listed.

October 15, 2004

Research Dollars Save Money, Lives, Scientists Tell Senate

May 3, 1991

In Brief: Loberg Resigns From Bristol-Myers Squibb; Bloomfield Heads Cancer Center At Ohio State

February 14, 1997

Endostatin Enters Phase II Trial For Neuroendocrine Tumors.

December 14, 2001

NIH Acting Director Kirschstein Preparing For Budget Hearings.

January 14, 2000

Senate Markup Would Give NCI $985 Million, Offers Prospect That Reductions In Grants Will Be Restored

December 10, 1982